spironolactone has been researched along with perindopril in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Alhenc-Gélas, F; Battaglia, C; Corvol, P; Plouin, PF | 1 |
| Gao, YJ; He, CC; Lee, RM; Li, N; Luo, BH; Su, CJ; Yi, JJ; Zeng, ZH | 1 |
| Czupryniak, L; Loba, J; Pawłowski, M; Saryusz-Wolska, M | 1 |
| DU, X; Lei, T; Liu, XH; Liu, XP; Luo, TY; Shi, JH; Wang, HY | 1 |
| Araki, N; Ishigami, T; Kakizoe, Y; Kitamura, K; Maeda, E; Minegishi, S; Tamura, K; Umemura, M; Umemura, S; Ushio-Yamana, H | 1 |
| Bhadada, SV; Patel, BM | 1 |
| Rickenbacher, P | 1 |
| Briasouli, A; Briasoulis, A; Fujisaki, T; Kuno, T; Takagi, H; Ueyama, H | 1 |
3 review(s) available for spironolactone and perindopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Heart failure with "mid-range" ejection fraction: a new clinical entity?]
Topics: Aged; Aminobutyrates; Benzimidazoles; Biomarkers; Biphenyl Compounds; Comorbidity; Coronary Disease; Drug Combinations; Drug Therapy, Combination; Evidence-Based Medicine; Heart Failure; Humans; Natriuretic Peptides; Perindopril; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Spironolactone; Stroke Volume; Survival Rate; Syndrome; Tetrazoles; Valsartan | 2018 |
Meta-Analysis Evaluating the Effects of Renin-Angiotensin-Aldosterone System Blockade on Outcomes of Heart Failure With Preserved Ejection Fraction.
Topics: Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Drug Combinations; Heart Failure; Hospitalization; Humans; Irbesartan; Mineralocorticoid Receptor Antagonists; Mortality; Network Meta-Analysis; Perindopril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Spironolactone; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan | 2020 |
2 trial(s) available for spironolactone and perindopril
| Article | Year |
|---|---|
Are angiotensin converting enzyme inhibition and aldosterone antagonism equivalent in hypertensive patients over fifty?
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Perindopril; Renin-Angiotensin System; Spironolactone; Therapeutic Equivalency | 1991 |
Circadian blood pressure variation and antihypertensive medication adjustment in normoalbuminuric type 2 diabetes patients.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Bisoprolol; Blood Pressure; Circadian Rhythm; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Indapamide; Indoles; Male; Middle Aged; Nitrendipine; Perindopril; Spironolactone | 2007 |
5 other study(ies) available for spironolactone and perindopril
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Control of vascular changes by renin-angiotensin-aldosterone system in salt-sensitive hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Antihypertensive Agents; Arteries; Benzimidazoles; Benzoates; Blood Pressure; Blood Vessels; Body Weight; Capsaicin; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Perindopril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Sodium, Dietary; Spironolactone; Telmisartan | 2004 |
[Effects of perindopril and spirolactone on plasma aldosterone and left atrial remodeling in a canine model of atrial fibrillation].
Topics: Aldosterone; Animals; Atrial Fibrillation; Atrial Function; Disease Models, Animal; Dogs; Male; Mineralocorticoid Receptor Antagonists; Perindopril; Spironolactone | 2009 |
Renin angiotensin antagonists normalize aberrant activation of epithelial sodium channels in sodium-sensitive hypertension.
Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Down-Regulation; Epithelial Sodium Channels; Eplerenone; Hypertension; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Perindopril; Renin; Sodium; Sodium Chloride, Dietary; Spironolactone; Tetrazoles | 2012 |
Type 2 diabetes-induced cardiovascular complications: comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril.
Topics: Animals; Animals, Newborn; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Metoprolol; Perindopril; Ramipril; Rats, Wistar; Spironolactone | 2014 |